Andros Pharmaceuticals Co.,Ltd (6917.TWO)

TWD 17.6

(-3.3%)

Annual Balance Sheets

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Total Assets 529.14 Million 329.59 Million 120.26 Million 153.34 Million 186.78 Million
Total Current Assets 452.68 Million 268.03 Million 78.25 Million 104.86 Million 132.98 Million
Cash And Short Term Investments 442.6 Million 254.68 Million 67.68 Million 92.74 Million 126.85 Million
Cash and Cash Equivalents 269.01 Million 88.19 Million 14.63 Million 13.79 Million 22.76 Million
Short Term Investments 173.59 Million 166.49 Million 53.04 Million 78.94 Million 104.09 Million
Net Receivables 8.54 Million - - - 5.46 Million
Inventory 1.08 Million 1.08 Million 1.05 Million 872 Thousand 609 Thousand
Other Current Assets 444 Thousand - - - 55 Thousand
Total Non-Current Assets 76.45 Million 61.56 Million 42.01 Million 48.48 Million 53.79 Million
Net PPE 28.69 Million 33.45 Million 38.24 Million 44.71 Million 50.08 Million
Good Will And Intangible Assets 42 Thousand 45 Thousand - - -
Good Will - - - - -
Intangible Assets - - - - -
Long-Term Investments -126.74 Million -139.29 Million -50.14 Million -76.04 Million -101.19 Million
Tax Assets 173.59 Million 166.49 Million - - -
Other Non Current Assets 868 Thousand 868 Thousand 53.91 Million 79.81 Million 104.91 Million
Other Assets - - - - -
Total Liabilities 58.03 Million 50.11 Million 51.6 Million 62.98 Million 59.88 Million
Total Current Liabilities 31.97 Million 19.67 Million 17.69 Million 24.7 Million 17.09 Million
Account Payables 5000.00 - - - -
Tax Payables - - - - -
Short Term Debt 5.09 Million 4.85 Million 4.67 Million 4.52 Million -
Deferred Revenue 26.46 Million - - - -
Other Current Liabilities 399 Thousand 14.82 Million 13.01 Million 20.18 Million 17.09 Million
Total Non Current Liabilities 26.06 Million 30.43 Million 33.9 Million 38.27 Million 42.79 Million
Long-Term Debt 22.02 Million 26.4 Million 29.88 Million 34.26 Million -
Deferred Revenue Non Current - - - - -
Deferred Tax Liabilities Non Current - - - - -
Other Non Current Liabilities 4.04 Million 4.03 Million 4.02 Million 4.01 Million 42.79 Million
Other Liabilities - - - - -
Total Equity 471.1 Million 279.48 Million 68.66 Million 90.35 Million 126.89 Million
Stock Holders Equity 471.1 Million 279.48 Million 68.66 Million 90.35 Million 126.89 Million
Common Stock 447.72 Million 347.72 Million 263.72 Million 254.23 Million 250.39 Million
Retained Earnings -369.66 Million -301.5 Million -260.32 Million -223.19 Million -187.3 Million
Accumulated other comprehensive income - - - - -
Common Stock Equity 471.1 Million 279.48 Million 68.66 Million 90.35 Million 126.89 Million
Capital Lease Obligation 27.12 Million 31.25 Million 34.56 Million 38.79 Million 43.36 Million
Total Investments 46.85 Million 27.2 Million 2.9 Million 2.9 Million 2.9 Million
Total Debt 27.12 Million 31.25 Million 34.56 Million 38.79 Million -
Net Debt -241.89 Million -56.94 Million 19.93 Million 24.99 Million -22.76 Million

Balance Sheet Charts